Skip to main content
ELV logo
ELV
(NYSE)
Elevance Health, Inc.
$300.74-- (--)
Loading... - Market loading

Elevance Health (ELV) Stock Price & Financial Analysis

Elevance Health Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$294.89 - $302.94
52-Week High$458.75
52-Week Low$273.71
Open$295.24
Volume1.19M
Average Volume (3M)1.19M
Market Cap67.55B
Shares Outstanding224.60M
P/E Ratio (TTM)11.84
Forward P/E12.35
Price to Sales (P/S)0.34
Price to Book (P/B)1.53
EV/EBITDA9.28
Revenue (TTM)199.13B
Net Income (TTM)5.66B
Free Cash Flow (TTM)3.17B
EPS (TTM)$25.53
Profit Margin2.84%
Operating Margin4.07%
Return on Equity (ROE)12.90%
Debt to Equity0.73
50-Day MA$318.02
200-Day MA$328.24
52-Week Change-31.01%
Annual Dividend$6.85
Dividend Yield2.29%
Payout Ratio26.83%
Last Dividend Ex-DateMar 10, 2026

Frequently Asked Questions About Elevance Health

What is the current stock price for ELV?

As of the latest trading session, ELV stock trades at $300.74. The 52-week range is $273.71–$458.75, with a day range of $294.89–$302.94.

What is the P/E ratio for ELV?

Elevance Health's trailing P/E ratio is 11.8, meaning investors pay $11.8 for every $1 of annual earnings. The forward P/E is 12.3, reflecting analyst expectations for future earnings. Elevance Health operates in the Healthcare sector.

Does ELV pay dividends?

Yes, Elevance Health pays a 2.29% annual dividend yield ($6.85 per share). The payout ratio is 26.8%. The last ex-dividend date was 2026-03-10.

What do analysts recommend for ELV?

Based on 7 analysts, the consensus for ELV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ELV?

Elevance Health's market capitalization is $67.55B, classifying it as a large-cap company. Elevance Health operates in the Healthcare sector within the Healthcare Plans industry.